| |
The 2010 Nagoya – Kuala Lumpur Supplementary
Protocol
on Liability and Redress
to the Cartagena Protocol on Biosafety
Earth Negotiations Bulletin ENB/IISD
Fifth Meeting of the Convention on Biological Diversity
Conference of the Parties Serving as the Meeting of the Parties
to the Cartagena Protocol on Biosafety (COP/MOP 5)
11-15 October 2010 | Nagoya, Japan
Summary and Brief Analysis (pp. 14-16)
Vol. 9 No. 533
Monday, 18 October 2010
"When historians look back at COP/MOP
5 in Nagoya, it is
possible that they will agree that this meeting marked a
defining
moment in the history of the Cartagena Protocol. Some may
credit the adoption of the Nagoya-Kuala Lumpur Supplementary
Protocol on Liability and Redress for setting the mood for a
smooth meeting without any major controversies. However, a
deeper analysis reveals a general shift in attitudes, positions
and political undercurrents that may have facilitated both
the successful conclusion of the negotiations on liability and
redress and the swift completion of other agenda items. COP/
MOP 5 provided an indication of what could be the beginning
of a new phase in international regulation of biotechnology:
one that is focused on cooperation in the management of the
risks associated with LMOs rather than on the struggle between
those who embrace biotechnology as a solution for many of the
world’s most pressing problems, and those who seek to defend
themselves against their utilization because they consider the
risks associated with LMOs greater than the benefits. This
analysis will first take a deeper look at these emerging trends,
followed by an investigation how they affected COP/MOP 5.
(... ...)
The final meeting of the Group of Friends of the Co-Chairs,
which was held directly prior to the COP/MOP, focused on
two outstanding issues: the definition of “products” of LMOs
and a provision on financial security. The debate on “products”
concerned the types of materials that are considered to be
within
the definition of LMOs. Some processed materials, such as
food products or synthesized biological compounds, may cause
damage to the environment or human health even though they
are not LMOs themselves. It is ambiguous whether the Biosafety
Protocol covers such processed materials, because they are not
included in the Protocol’s definition of LMOs, despite being
referenced in several articles and annexes. Some feared that
adding a definition of “products” could broaden the scope of
the liability regime beyond that of the Biosafety Protocol,
while
others maintained that without the definition, the Supplementary
Protocol would not apply to some types of damage covered by
the Biosafety Protocol...."
|
ASIL Insight
January 10, 2011
Volume 15, Issue 41
The 2010 Nagoya-Kuala Lumpur Supplementary Protocol: A
New Treaty Assigning Transboundary Liability and Redress
for Biodiversity Damage Caused by Genetically Modified
Organisms
By Anastasia Telesetsky
" ... The key actors who may
potentially trigger a claim under the Supplementary
Protocol are the “operators” who include any person in “direct or
indirect
control” of an LMO. Just as the International Convention on Civil
Liability for
Compensation for Oil Pollution Damage was negotiated to apply to
private
actors,[18] the term “owner” in the Supplementary Protocol was
defined
broadly to include non-state actors, including any group in the
chain of
custody of LMOs.[19]
A major source of contention was whether the text would cover not
just LMOs
but “products thereof” (such as tofu produced from transgenic
soybeans).
Some States argued that the language “products thereof” would expand
the
Supplementary Protocol beyond the scope of the Cartagena Protocol.
The
language was ultimately removed from the text, but the Parties
agreed that
States could apply the Supplementary Protocol to damage caused by
processed materials from LMOs as long as a causal link is
established.[20]
Applying domestic law on causation, a claimant must demonstrate a
causal
link between the claimed damage and the introduction of an LMO
across a
boundary.[21] ... "
(...) (...)
For the time
being, however, the failure to attract ratifications from major
biotech producing States raises questions about the legitimacy of
the
Supplementary Protocol as a tool for ensuring appropriate liability
and redress
for ecological damage and impacts on human health. As noted in the
Conference of Parties Decision BS-V/11, the private sector has
undertaken
some initiatives to ensure recourse in the event of environmental
damage
caused by LMOs.[41] Some argue that it was the leadership from the
private
biotech sector, by agreeing to subject its industry to civil
liability to ensure a
generally liberalized market in LMOs, that made it possible for
States to
accept the current draft of the Supplementary Protocol. In 2010,
BASF, Bayer
CropScience, Dow AgroSciences, DuPont, Monsanto, and Syngenta signed
“The Compact: A Contractual Mechanism for Response in the Event of
Damage to Biological Diversity Caused by the Release of a Living
Modified
Organism.”[42] As members to the Compact, these companies agreed to
binding arbitration under the auspices of the Permanent Court of
Arbitration if
a company has released an LMO that is alleged to have caused damage
to
biological diversity. As corporate leaders, these companies
indicated that they
expect Compact members to be properly insured to absorb potential
financial
losses.
Interestingly enough, the Compact, in contrast to the Supplementary
Protocol,
provided for specifically elaborated legal standards[43] and an
industry
contract to limit the partiesʼ liability.[44] Similarly, where the
Supplementary
Protocol requires a response for damage arising from both
intentional and
unintentional transboundary movements,[45] the Compact members
limited
member liability for transboundary movements of LMOs to misuses.[46]
Likewise, where the Supplementary Protocol provides an open-ended
definition for “significant” adverse effects, the Compact
specifically limited
compensable environmental damage.[47] Notably, the Compact, unlike
the
Supplementary Protocol, does not explicitly address adverse effects
on human
health...."
http://asil.org/files/2010/insights/insights_110107.pdf |
Nagoya Meeting Spawns New Biosafety Treaty
Bridges
Trade BioRes •
Volume 10 •
Number 19 •
25th October 2010
“...There remain serious issues
in need of priority consideration and urgent action,” said Sebastian
Marino of Palau, one of two officials representing Asia-Pacific
countries. Marino said that before the Protocol can be successfully
carried out, his region must address shortages in capacity building,
financial resources, information exchange, and technology transfer....
In addition, the Asia and
Pacific group would like to highlight the equal importance of
socio-economic considerations,” Marino said, alluding to the right
of developing countries to refuse to import GM products if they are
perceived to damage the socio-economic well-being of the country or
community into which it is being introduced. ..."
http://ictsd.org/i/news/biores/90190/ |
THIRD
WORLD RESURGENCE
Double Issue No.
242/243
Oct./Nov. 2010
New
treaty on liability for GMO damage
"... The two main substantive issues that were
the subject of the negotiations - whether or not products of LMOs ('products
thereof') should be covered by the scope of the Supplementary
Protocol, and the provisions on financial security - were finally
resolved after very long and difficult negotiations which dragged on
for an extra two days beyond the scheduled time. While mention of 'products
thereof' was eventually removed from the operative text of the
Supplementary Protocol, the report of the meeting records an
understanding that Parties may apply the Supplementary Protocol to
damage caused by processed materials that are of LMO origin,
provided that a causal link is established between the damage and
the LMO in question. This understanding is significant as it
clarifies that the Supplementary Protocol may apply to damage caused
not only by LMOs but also by their products, which may be non-living
material. The scope of the Cartagena Protocol is limited only to
living modified organisms; however, the issue of products thereof is
covered by the Cartagena Protocol with regard to information
sharing, and in information required in notifications for the
advance informed agreement (AIA) and simplified procedure, as well
as in the principles for risk assessment.The right of Parties to
provide for financial security is also enshrined in the
Supplementary Protocol. Financial security is important to ensure
that, if for any reason, the responsible party cannot pay for the
damage caused by an LMO, there will be some means available to do so.
(... ...)
The birth of this new multilateral
environmental agreement has been a difficult one, with many
compromises made along the way. A major change has been the shift
from a civil liability regime to an administrative approach focusing
on response measures, which emerged from the ashes of the near-collapsed
negotiations in Bonn
in 2008. ...)
http://www.twnside.org.sg/title2/resurgence/2010/242-243/cover05.htm |
|